Research output

Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • Henon, C.
  • Auclin, E.
  • Mezquita, L.
  • Ferrara, R.
  • Audigier-Valette, C.
  • Mazieres, J.
  • Lefebvre, C.
  • Rabeau, A.
  • Le Moulec, S.
  • Cousin, S.
  • Duchemann, B.
  • le Pechoux, C.
  • Botticella, A.
  • Ammari, S.
  • Gazzah, A.
  • Caramella, C.
  • Adam, J.
  • Lechapt, E.
  • Planchard, D.
  • Besse, B.

Associated organisations

    Research areas

  • NSCLC, Checkpoint inhibition, Brain metastases, survival, Disease specific Graded Prognostic Assessment, PATIENTS PTS, OPEN-LABEL, NIVOLUMAB, PEMBROLIZUMAB, DOCETAXEL, SYSTEM, EFFICACY, LIFE
View graph of relations


Original languageEnglish
Pages (from-to)1244-1254
Number of pages11
JournalJournal of Thoracic Oncology
Issue number7
Publication statusPublished - Jul 2019